NCT01258517

Brief Summary

The purpose of this study is to assess changes in cerebral oxygenation during two different types (beractant and poractant) and two different routes (double lumen or single lumen endotracheal tube) of surfactant administration using near infrared spectroscopy (NIRS).

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2010

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 7, 2010

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 13, 2010

Completed
7.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

September 5, 2016

Status Verified

November 1, 2010

Enrollment Period

7.6 years

First QC Date

December 7, 2010

Last Update Submit

September 1, 2016

Conditions

Keywords

RDSsurfactantcerebral oxygenationnear infrared spectroscopy

Outcome Measures

Primary Outcomes (1)

  • to determine the optimal and the most safe surfactant administration technique with regard to cerebral oxygenation as measured by near infrared spectroscopy in low birth weigh infants

    up to 36 weeks

Study Arms (1)

group 1, group 2, group 3, group 4

administration of beractant with single lumen ET tube administration of poractant with single lumen ET tube administration of beractant with double lumen ET tube administration of poractant with double lumen ET tube

Device: near infrared spectroscopy (INVOS 5100)

Interventions

monitorization of cerebral oxygenation by INVOS 5100 during surfactant administration

group 1, group 2, group 3, group 4

Eligibility Criteria

Age23 Weeks - 32 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

\<32 week or \<1500 g required surfactant treatment for established RDS

You may qualify if:

  • Clinical diagnosis of respiratory distress syndrome \<32 gestational weeks and/or \<1500 g birthweight

You may not qualify if:

  • major congenital anomalies complex congenital heart diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zekai Tahir Burak Maternity Teaching Hospital, Neonatal Intensive Care Unit

Ankara, 06100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Respiratory Distress SyndromePremature Birth

Interventions

Spectroscopy, Near-Infrared

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration DisordersObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisSpectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 7, 2010

First Posted

December 13, 2010

Study Start

November 1, 2010

Primary Completion

June 1, 2018

Study Completion

December 1, 2018

Last Updated

September 5, 2016

Record last verified: 2010-11

Locations